School of Medicine
Showing 301-350 of 353 Results
-
Imran Thobani
Postdoctoral Scholar, Ophthalmology
BioDr. Imran Thobani is a postdoctoral scholar in Ophthalmology co-advised by Dan Yamins and Andreas Tolias as part of the Enigma project. He is interested in building large-scale predictive models of the brain that he thinks will be useful for both scientific insights and downstream biomedical applications. He did his PhD at Stanford, where he was trained in both philosophy of neuroscience and computational neuroscience, applying this training to develop better methods for comparing artificial neural network models to the brain.
-
Daniel SW Ting
Adjunct Clinical Associate Professor, Ophthalmology
BioDaniel Ting, MD, PhD, Stanford Adjunct Associate Professor and Duke-NUS Jong Soy Leong Professor, is one of the world's leading clinician-AI scientists, vitreoretinal surgeons, technology innovators and entrepreneurs, with expertise spanning retinal medicine and surgery, AI and healthcare technology. His work sits at the intersection of medicine, AI, innovation and technology translation. A former US-ASEAN Fulbright Scholar at the Johns Hopkins University Applied Physics Laboratory and School of Medicine, his research spans machine learning, deep learning, large language models, multimodal foundation models, explainable AI and privacy-preserving technologies, alongside safe, responsible and ethical clinical AI. He has contributed to international consensus and reporting initiatives including STARD-AI, QUADAS-AI and DECIDE-AI.
Professor Ting works across the full translational spectrum of AI in healthcare, from algorithm development and multimodal foundation models to generative and agentic AI, clinical implementation, regulatory science, health economics and commercialization. He is Founding Co-Director of the SingHealth Duke-NUS Artificial Intelligence in Medicine Institute (AIMI), Director of the SingHealth AI Office, Chief Data & Digital Officer of the Singapore National Eye Centre, and Head of AI & Digital Innovation at the Singapore Eye Research Institute. He serves on Singapore's Ministry of Health AI Steering Committee and is a core leader of SIMFONI, Singapore's national programme for sovereign multimodal foundation models in healthcare.
His research has advanced the development, validation and real-world deployment of medical AI, including national-scale AI-enabled diabetic retinopathy screening, health-economic evaluation, privacy-preserving AI, medical imaging foundation models and responsible generative AI. More recently, his work has expanded into sovereign agentic AI and enterprise AI orchestration, combining frontier models, specialised agents, institutional knowledge, verification and structured human oversight for regulated environments.
Professor Ting has authored more than 400 peer-reviewed publications, attracting more than 45,000 citations with an H-index above 86, including influential work in JAMA, The Lancet, Nature Medicine, Nature Biomedical Engineering, The Lancet Digital Health and NEJM AI. He was recognised in the World's Top 100 AI Power List (2024) alongside AI leaders including Jensen Huang, Fei-Fei Li and Yann LeCun. He has been named among Stanford University's World's Top 2% Scientists (2022–2026), the Top 100 Power List in Ophthalmology, and the World's Top 10 Ophthalmic Innovators (2025). Major honours include Singapore's Young Scientist Award, National Clinician Scientist Award, APAO Nakajima Award, APVRS Ian Constable Award, ARVO Bert Glaser Award and Macula Society Evangelos Gragoudas Award.
Professor Ting serves on the International Advisory Board of The Lancet Digital Health, is Section Editor for AI at the British Journal of Ophthalmology, and holds editorial leadership roles with Ophthalmology, Ophthalmology Retina and Ophthalmology Science. He also holds international leadership positions across the American Academy of Ophthalmology and major Asia-Pacific ophthalmology and vitreoretinal societies.
Beyond academia, Professor Ting is a serial inventor, start-up founder and technology entrepreneur, co-founding ventures spanning medical AI, ophthalmology, healthy longevity and sovereign agentic AI. His work bridges Stanford and Silicon Valley's frontier AI and innovation ecosystem with Singapore's integrated healthcare and national AI infrastructure, translating frontier AI into trusted and scalable technologies. His mission is to build the next generation of trusted, sovereign and clinically intelligent AI systems, moving healthcare AI from algorithms to infrastructure, from prediction to reasoning, and from scientific discovery to global-scale impact. -
Andreas Tolias
Professor of Ophthalmology
BioAndreas Tolias is a faculty member at Stanford University, where he co-leads the Enigma Project. His research lies at the interface of neuroscience and AI, combining large-scale neuroscience experiments with machine learning to uncover the principles of natural intelligence. By focusing on perceptual inference and decision-making, his lab integrates systems and computational neuroscience with AI to decipher the network-level principles of intelligence. Dr. Tolias’s work aims to reverse-engineer these principles to create AI systems that are smarter, more robust, trustworthy, and efficient, while providing a powerful platform to test brain algorithms under complex natural tasks. He earned his B.A. and M.A. in Natural Sciences from the University of Cambridge, a Ph.D. in Systems and Computational Neuroscience from MIT, and completed postdoctoral training in Neuroscience and Machine Learning at the Max Planck Institute for Biological Cybernetics in Tübingen.
-
Sirin Triwutpipatkul
Affiliate, Ophthalmology Research/Clinical Trials
Visiting Scholar, Ophthalmology Research/Clinical TrialsBioSirin Triwutpipatkul, MD is a board-certified ophthalmologist and fellowship-trained cornea and refractive specialist. She completed her ophthalmology residency and cornea fellowship at the Department of Ophthalmology, King Chulalongkorn Memorial Hospital, Bangkok, Thailand. She also serves in Thailand's Ministry of Justice healthcare system, participating in nationwide collaborative research.
Her clinical interests include corneal disease, corneal transplantation, ocular surface disease, infectious keratitis, dry eye disease, and refractive surgery. Her research focuses on randomized clinical trials, international collaborations, and the application of artificial intelligence in corneal and refractive diseases.
Dr.Sirin is currently a Clinical and Research fellow at the Byers Eye Institute at Stanford University, where she is involved in clinical and international research in cornea and external diseases.
Outside of medicine, she enjoys exploring new places, traveling, cycling, and is always on the hunt for a great local coffee shop :) -
Janice Marie Turi
Web and Communications Specialist, Ophthalmology Operations
Current Role at StanfordSr. Manager, Web and Communications
Ophthalmology Operations -
Gabriel Velez, MD, PhD
Resident in Ophthalmology
BioGabriel Velez is a PGY3 ophthalmology resident at Stanford. He received his bachelor’s degree in molecular biology from Winona State University in 2014. He completed his MD and PhD degrees at the University of Iowa. His PhD research focused on studying the structure of the calpain-5 (CAPN5) protein and its role in the development of Neovascular Inflammatory Vitreoretinopathy (NIV), a rare blinding eye disease. His research interests include translational proteomics, retinal disease, ocular oncology, structural biology, biophysical chemistry, drug design, and bioinformatics.
-
Karen Wai, MD
Clinical Assistant Professor, Ophthalmology
BioDr. Wai is a board-certified ophthalmologist and fellowship-trained vitreoretinal surgeon with Stanford Health Care Byers Eye Institute. She is also a clinical assistant professor of ophthalmology in the Department of Ophthalmology at Stanford University School of Medicine.
Dr. Wai is a retina specialist who diagnoses and treats retinal and macular diseases, including age-related macular degeneration, diabetic retinopathy, retinal vascular occlusions (blockages), and retinal tears/detachments. The retina is a tissue layer in the back of the eye. It converts light into signals that the brain then interprets as images. The macula is the part of the retina responsible for central (straight ahead) vision. Diseases of the retina and macula can cause low vision and vision loss.
Dr. Wai’s research interests include working with data from electronic health record databases to improve patient outcomes. She has researched morbidity and mortality (illness and death) rates in patients with retinal vein occlusions and retinal artery occlusions. A retinal vein occlusion is a blocked vein to the retina that can cause vision loss. A retinal artery occlusion is when an artery to the retina is blocked, which is also sometimes referred to as eye stroke. Dr. Wai has also examined the effects of systemic medications on the retina. She has won several ophthalmology awards, including the Heed Fellowship and Harvard Medical School’s Excellence in Clinical Instruction Resident Award.
Dr. Wai has published in more than 40 peer-reviewed journals, including Ophthalmology, American Journal of Ophthalmology, and JAMA Ophthalmology. She has presented research at meetings and conferences around the United States.
Dr. Wai is a member of the American Board of Ophthalmology. -
Grzegorz Walkiewicz
Postdoctoral Scholar, Ophthalmology
BioGrzegorz (Greg) Walkiewicz, PhD, is a neuroscientist with a strong background in retinal and neurodegenerative disease research. He completed his PhD at KU Leuven (Belgium), focusing on tau pathology and Alzheimer’s disease. His research explores the connection between brain and eye pathology, with particular interest in pTau, Aβ, and microglial activation. He has worked extensively with transgenic mouse models as well as human brain and retinal tissues. He recently joined Stanford University to investigate INPP5K-related mechanisms in retinal ganglion cell degeneration.
-
Brian A. Wandell
Isaac and Madeline Stein Family Professor and Professor, by courtesy, of Electrical Engineering, of Ophthalmology and of Education
Current Research and Scholarly InterestsModels and measures of the human visual system. The brain pathways essential for reading development. Diffusion tensor imaging, functional magnetic resonance imaging and computational modeling of visual perception and brain processes. Image systems simulations of optics and sensors and image processing. Data and computation management for reproducible research.
-
Sean K. Wang, MD
Clinical Instructor, Ophthalmology
BioDr. Sean K. Wang is a board-certified and fellowship-trained ophthalmologist with Stanford Health Care. He is also an assistant professor in the Department of Ophthalmology, Retina Division at Stanford University School of Medicine.
Dr. Wang specializes in treating diseases of the retina and macula, including age-related macular degeneration, diabetic retinopathy, central serous chorioretinopathy, and retinal vascular occlusions. He is committed to providing individualized, high-quality care to achieve the best possible outcomes for his patients.
Dr. Wang’s research aims to accelerate the development of safe and effective genetic therapies. By integrating approaches from genetics, immunology, synthetic biology, computer science, and medicine, his lab seeks to discover and translate new treatments for human diseases with an emphasis on blinding disorders.
His work has been published in leading scientific journals, including Nature, Nature Biotechnology, Journal of Clinical Investigation, and Proceedings of the National Academy of Sciences. Dr. Wang has been recognized as a STAT Wunderkind, Forbes 30 Under 30, and is a recipient of the American Society for Clinical Investigation Emerging-Generation Award and Burroughs Wellcome Fund Career Award for Medical Scientists, among other honors. -
Sophia Y. Wang, MD, MS
Assistant Professor of Ophthalmology
Current Research and Scholarly InterestsI use and integrate a wide variety of data sources in my research, spanning both structured and unstructured forms, including national survey datasets, health insurance claims data, patient generated online text, surgical video, and electronic health records. I investigate outcomes of treatments for glaucoma and cataract, as well as other areas of ophthalmology. My focus is on developing artificial intelligence methods to predict ophthalmology outcomes, while ensuring fairness.
-
Sui Wang, PhD
Associate Professor of Ophthalmology
Current Research and Scholarly InterestsOur research focuses on unraveling the molecular mechanisms underlying retinal development and diseases. We employ genetic and genomic tools to explore how various retinal cell types, including neurons, glia, and the vasculature, respond to developmental cues and disease insults at the epigenomic and transcriptional levels. In addition, we investigate their interactions and collective contributions to maintain retinal integrity.
1. Investigating retinal development:
We utilize genetic tools and methods such as in vivo plasmid electroporation and CRISPR to dissect the roles of cis-regulatory elements and transcription factors in controlling retinal development.
2. Understanding diabetes-induced cell-type-specific responses in the retina:
Diabetes triggers a range of multicellular responses in the retina, such as vascular lesions, glial dysfunction, and neurodegeneration, all of which contribute to retinopathy. We delve into the detailed molecular mechanisms underlying these diabetes-induced cell-type-specific responses and the pathogenesis of diabetic retinopathy.
3. Developing molecular tools for labeling and manipulation of specific cell types in vivo:
Cis-regulatory elements, particularly enhancers, play pivotal roles in directing tissue- and cell-type-specific expression. Our interest lies in identifying enhancers that can drive cell type-specific expression in the retina and brain. We incorporate these enhancers into plasmid or AAV-based delivery systems, enabling precise labeling and manipulation of specific cell types in vivo. -
Wenmin Wang
Postdoctoral Scholar, Ophthalmology
Current Research and Scholarly InterestsI am particularly interested in identifying therapeutic strategies for various eye disorders and investigating the mechanisms by which defects in inositol phosphatases lead to the disruption of primary cilia function and eye diseases by using Omics.
-
Merve Ceren Yasli
Visiting Instructor, Ophthalmology Research/Clinical Trials
BioByers Eye Institute - Nowatzky Lab
-
Tsai-Chu Yeh, MD, MTM
Postdoctoral Scholar, Ophthalmology
BioDr. Tsai-Chu Yeh is a dedicated vitreoretinal surgeon and scientist. During residency, she was honored with the Best Resident Award, and her research has been featured in Medscape News and the American Academy of Ophthalmology, earning numerous awards from the Association for Research in Vision and Ophthalmology, American Society of Retina Specialists, Fuji Retina, and the Taiwan Retina and Ocular Inflammation Society.
Beyond advancing science, Dr. Yeh is deeply committed to inspiring the next generation by making translational medicine both accessible and impactful. She received the Best Teacher Award for five consecutive years and was promoted to assistant professor as one of the youngest scholars in her field.
Motivated by a passion to bridge science and medicine, she joined the Mahajan Lab at Stanford University as a postdoctoral scholar, where she developed expertise in molecular genetics, honed her passion for discovery, and embraced the lessons of resilience and perseverance. Her research focuses on identifying protein signatures and molecular mechanisms underlying vitreoretinal diseases, aiming to pave the way for targeted, vision-restoring therapies.
Outside the lab and clinic, Dr. Yeh is a true renaissance woman. She finds joy in reading, music and art, and cherishes time with her family and friends. She also enjoys traveling, tennis, and golf. Her vibrant spirit infuses everything she does—bringing energy, empathy, and excellence to her work as a clinician, scientist, and surgeon. -
Charles Yu MD
Assistant Professor of Ophthalmology
Current Research and Scholarly InterestsCorneal opacity is a leading cause of blindness. Cornea transplantation is at high risk of rejection when there is pre-existing vascularization of the cornea and in pediatric patients. Cornea transplant shortage remains a worldwide problem with millions on waitlists. Our laboratory is developing multiple strategies for treatment of corneal blindness. We are testing advanced materials and designs for keratoprostheses with the goal of reducing complications and easing surgical implantation. We are also developing intraocular electronic display prostheses for bypassing cornea opacity, a novel strategy that could allow for high quality vision without corneal clarity.
